AnalysisNews

AZTR today

$0.61-$0.06 (-8.99%)close Nov 13, 2026

Trend

DailyDowntrend (starting)

4 hourSymmetric Triangle

1 hourStrong Bearish

15 minStrong Bearish

5 minStrong Bearish

Daily trend turns up above $0.19

Key levels

Resistance$0.82

Resistance$0.62

Support$0.43

Support$0.23

Latest news & SEC filings

EarningsAzitra Posts Q3 2026 Results, Gives Business Update

EarningsAnitra reports Q3 EPS of $(0.29), missing $(0.23) estimate

SEC FilingAzitra, Inc. filed a report on a major company event (Form 8-K)

All AZTR news →

About Azitra

Azitra is a clinical-stage biopharmaceutical company pursuing precision dermatology therapies. It creates modified proteins along with live biotherapeutic products applied to the skin, backed by a collection of bacterial strains, machine learning screening tools, and licensed genetic engineering methods. Its lead programs target Netherton syndrome, rash caused by EGFR inhibitor cancer treatment, and ichthyosis vulgaris. The company is based in the United States and works with academic research partners.

Based on the company's 10-K filed Feb 27, 2026.

NYSE · Healthcare

Azitra, Inc. (AZTR)

$0.61-0.06 (-8.99%)
WATCHLISTGrade: C+Risk: LOW
1D5D1M1Y5YMaxSign up for all timeframes
0.811.031.251.470.61Oct 1Oct 9Oct 29Nov 6
High0.67
Low0.61
Open0.66
Volume67K
Avg Vol5.01M
VWAP0.64
30d High1.70
30d Low0.59
30d Chg-63.24%

What Is the Price Target for AZTR?

SEPT Low Target

$0.00

SEPT Mid Target

$0.00

SEPT High Target

$0.00

Analyst Consensus

$0.00

Current: $0.62Upside: +0.0%Confidence: 20%Method: No Coverage

Is AZTR a Buy or Sell Right Now?

48
Investability Score
WATCHLIST12-18 months
News summary · last 30 days
Oct 26▲ UpShort squeezeDilutionProduct3 articles
Azitra shares surged 47.12% to close at $1.53, with trading briefly paused by a circuit breaker after the stock climbed as much as 88.47% intraday on heavy volume of 138.5 million shares. The rally was fueled by a short squeeze, while the company also announced it is pausing its at-the-market stock sales indefinitely after raising only about $126 in gross proceeds from selling 1,000 shares between September 28 and October 26, 2026. Additionally, Azitra said it will present progress on its ATR-COSF cosmetic program for fine lines and wrinkles at the Bio-Europe event on November 10, with initial first-in-human study results expected by the end of 2026. The combination of a short squeeze, reduced dilution concerns, and upcoming product updates signals a bullish direction for the stock.
Critical news
Oct 26HIGHPrice move report

Thesis

  • •Revenue growing -98.9% YoY with STRONG trend — consistent growth.
  • •SEC filings signal active product innovation — 1 new product/expansion keywords detected in 10-K. R&D investment rising.

AI-Powered Trading Signals

Trained on trillions of real market data to read price action and give you a simple, emotionless trading strategy for AZTR.

Start Free Trial →

Is AZTR Overvalued or Undervalued?

Valuation Verdict

N/A

Methods Used

N/A

Fair Value

$N/A

23

Moat Score

NONE

0/9

Piotroski Score

-24.4

Altman Z-Score

What Is Smart Money Doing with AZTR?

Insider Signal

NEUTRAL

2 buys / 0 sells (90d)

Congress Signal

NEUTRAL

0 buys / 0 sells (90d)

Institutional

N/A

Short Squeeze Risk

LOW

Signal: NEUTRAL

Track Smart Money Across 4,000+ Stocks

Insider trades, congress trades, institutional flows, and short interest — updated daily with real-time alerts.

See All Smart Money Signals →

AZTR Growth Story

Revenue YoY

-98.9%

3yr Revenue CAGR

N/A%

EPS Growth YoY

85.67%

FCF Growth YoY

-10.4%

Revenue Trend

STRONG

Dark Pool Trades for AZTR

PREVIEW

SEPT Investing tracks real-time dark pool institutional trades for AZTR, including block trade sizes, dollar values, and buy/sell side classification. Dark pool trades reveal where institutional investors are positioning before moves become visible on public exchanges.

TimePriceSizeValueSide
21:49:57$0.631,573$$984SELL
19:13:36$0.621,000$$625SELL
19:05:30$0.622,090$$1KSELL
15:06:32$0.621,200$$742SELL
14:49:55$0.651,338$$870SELL

5 dark pool trades shown · $$5K preview volume

Real-time institutional flow, block trades, and net positioning

See all dark pool activity

Full AI Research Report

SEPT's Trading AI has generated a free, downloadable PDF research report for Azitra, Inc. (AZTR) covering valuation analysis, financial health assessment, growth projections, smart money tracking, earnings and key price levels. For research only, not investment advice.

Report includes: PDF download, detailed valuation models (DCF, P/E, EV/EBITDA), institutional flow analysis, congress and insider trade tracking, FinBERT news sentiment (3 articles analyzed), and SEC filing intelligence...

AI-Powered Trading Signals.

Trained on trillions of real market data to read price action and give you a simple, emotionless trading strategy. SEPT tells you when to buy, when to sell, and grades every stock so you never trade blind.

Try SEPT Free for 7 Days →

AZTR — frequently asked questions

What is AZTR stock price today?

Azitra, Inc. (AZTR) is at $0.61, down 8.99% (-$0.06) at the Nov 13, 2026 close.

Why is AZTR stock moving today?

Latest AZTR news — Nov 13, 2026: Azitra Posts Q3 2026 Results, Gives Business Update · Nov 12, 2026: Anitra reports Q3 EPS of $(0.29), missing $(0.23) estimate

Why did AZTR stock move on Oct 26, 2026?

Azitra shares surged 47.12% to close at $1.53, with trading briefly paused by a circuit breaker after the stock climbed as much as 88.47% intraday on heavy volume of 138.5 million shares. The rally was fueled by a short squeeze, while the company also announced it is pausing its at-the-market stock sales indefinitely after raising only about $126 in gross proceeds from selling 1,000 shares between September 28 and October 26, 2026.

Did AZTR beat earnings?

AZTR last reported on Aug 12, 2026: EPS -$0.17 vs -$0.12 expected — a miss of 47.8%.

What is AZTR's P/E ratio?

AZTR trades at a P/E of 9.8 vs a Healthcare average of 17.7.

Does AZTR pay a dividend?

AZTR does not currently pay a dividend.

What are AZTR support and resistance levels?

Support: $0.43, $0.23, $0.05. Resistance: $0.62, $0.82, $1.36.

What are insiders doing with AZTR?

Insider activity: NEUTRAL, 2 buys and 0 sells in the last 90 days.

What is the latest news on AZTR?

Nov 13, 2026: Azitra Posts Q3 2026 Results, Gives Business Update · Nov 12, 2026: Anitra reports Q3 EPS of $(0.29), missing $(0.23) estimate · Nov 12, 2026: Azitra, Inc. filed a report on a major company event (Form 8-K)